Total Payments
$20,296
2024 Payments
$1,459
Companies
46
Transactions
273
Medicare Patients
20,628
Medicare Billing
$1.6M
Payment Breakdown by Category
Consulting$10,080 (49.7%)
Food & Beverage$6,568 (32.4%)
Travel$2,799 (13.8%)
Other$500.00 (2.5%)
Education$349.15 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,080 | 3 | 49.7% |
| Food and Beverage | $6,568 | 249 | 32.4% |
| Travel and Lodging | $2,799 | 14 | 13.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 2.5% |
| Education | $349.15 | 6 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $5,935 | 58 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $5,495 | 24 | $0 (2023) |
| Astellas Pharma US Inc | $3,921 | 42 | $0 (2024) |
| AngioDynamics, Inc. | $987.87 | 5 | $0 (2024) |
| Allergan, Inc. | $585.99 | 6 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $523.50 | 8 | $0 (2020) |
| ABBVIE INC. | $385.90 | 25 | $0 (2024) |
| Augmenix, Inc. | $324.79 | 4 | $0 (2018) |
| PFIZER INC. | $280.67 | 19 | $0 (2024) |
| Amgen Inc. | $223.28 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,459 | 25 | AngioDynamics, Inc. ($959.19) |
| 2023 | $427.98 | 13 | Dendreon Pharmaceuticals LLC ($125.60) |
| 2022 | $489.79 | 28 | Janssen Biotech, Inc. ($212.86) |
| 2021 | $345.77 | 23 | Janssen Biotech, Inc. ($124.55) |
| 2020 | $461.07 | 22 | Janssen Biotech, Inc. ($174.10) |
| 2019 | $1,640 | 50 | Dendreon Pharmaceuticals LLC ($367.28) |
| 2018 | $6,373 | 47 | Janssen Biotech, Inc. ($4,938) |
| 2017 | $9,100 | 65 | Dendreon Pharmaceuticals LLC ($4,236) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Oncology | ||||||
| 12/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $9.08 | General |
| 09/25/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/23/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/18/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $40.41 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/17/2024 | Agiliti Health, Inc. | Sonablate HIFU (Device), Koelis Trinity Fusion Biopsy System | Food and Beverage | Cash or cash equivalent | $23.72 | General |
| Category: Speciality surfaces; moveable medical equipment | ||||||
| 06/13/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $62.78 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/13/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.53 | General |
| 05/08/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $20.29 | General |
| 04/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Biological | ||||||
| 04/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Travel and Lodging | Cash or cash equivalent | $217.06 | General |
| Category: OS | ||||||
| 03/29/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/13/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Continence Care | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Oncology | ||||||
| 03/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/05/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Travel and Lodging | In-kind items and services | $246.49 | General |
| Category: OS | ||||||
| 03/05/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: OS | ||||||
| 02/23/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Travel and Lodging | In-kind items and services | $489.96 | General |
| Category: OS | ||||||
| 02/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 02/21/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 02/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 49 | 3,953 | 13,315 | $803,035 | $307,600 |
| 2022 | 52 | 5,608 | 21,148 | $1.4M | $436,360 |
| 2021 | 52 | 5,798 | 28,285 | $1.5M | $497,089 |
| 2020 | 48 | 5,269 | 22,334 | $1.3M | $349,710 |
Total Patients
20,628
Total Services
85,082
Medicare Billing
$1.6M
Procedure Codes
201
All Medicare Procedures & Services
201 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 651 | 971 | $193,229 | $83,839 | 43.4% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2023 | 22 | 22 | $121,000 | $47,323 | 39.1% |
| J3490 | Unclassified drugs | Office | 2023 | 19 | 61 | $48,900 | $28,400 | 58.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 278 | 357 | $47,838 | $21,479 | 44.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 97 | 117 | $42,822 | $20,236 | 47.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 22 | 90 | $60,750 | $12,017 | 19.8% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 50 | 51 | $28,050 | $9,596 | 34.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 39 | 40 | $15,840 | $7,051 | 44.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 699 | 820 | $20,500 | $6,865 | 33.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 308 | 380 | $19,000 | $6,848 | 36.0% |
| 51705 | Simple change of bladder tube | Office | 2023 | 16 | 96 | $18,240 | $6,584 | 36.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 50 | 50 | $11,900 | $5,048 | 42.4% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 14 | 144 | $8,640 | $4,952 | 57.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $13,062 | $4,234 | 32.4% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 35 | 35 | $29,575 | $3,840 | 13.0% |
| 11980 | Placement of hormone pellet under skin | Office | 2023 | 19 | 52 | $10,348 | $3,341 | 32.3% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 45 | 45 | $15,750 | $3,241 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 24 | $6,480 | $3,124 | 48.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 71 | 119 | $5,950 | $3,010 | 50.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 228 | 328 | $10,496 | $2,384 | 22.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $5,000 | $1,918 | 38.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 394 | 555 | $2,775 | $1,890 | 68.1% |
| 74170 | Ct scan of abdomen before and after contrast | Office | 2023 | 13 | 14 | $6,300 | $1,837 | 29.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 38 | $4,560 | $1,800 | 39.5% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 85 | 94 | $4,700 | $1,694 | 36.0% |
About Dr. David Bock, MD
Dr. David Bock, MD is a Urology healthcare provider based in Overland Park, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386693026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Bock, MD has received a total of $20,296 in payments from pharmaceutical and medical device companies, with $1,459 received in 2024. These payments were reported across 273 transactions from 46 companies. The most common payment nature is "Consulting Fee" ($10,080).
As a Medicare-enrolled provider, Bock has provided services to 20,628 Medicare beneficiaries, totaling 85,082 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 201 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Overland Park, KS
- Active Since 05/09/2006
- Last Updated 04/25/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1386693026
Products in Payments
- PROVENGE (Drug) $5,495
- Erleada (Drug) $5,271
- NANOKNIFE (Device) $987.87
- ERLEADA (Drug) $585.82
- Xofigo (Drug) $523.50
- BOTOX OAB (Drug) $500.00
- SpaceOAR (Device) $324.79
- MYRBETRIQ (Drug) $302.23
- XTANDI (Drug) $293.64
- ZYTIGA (Drug) $186.80
- LUPRON DEPOT (Drug) $160.40
- PYLARIFY (Drug) $152.97
- PLUVICTO (Drug) $136.84
- Urolift - UL400 (Device) $131.03
- XGEVA (Biological) $118.08
- Myrbetriq (Drug) $107.36
- Prolia (Biological) $105.20
- Androgel (Drug) $75.60
- BOTOX (Biological) $70.48
- JELMYTO (Drug) $69.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Overland Park
Nathaniel Ballek, M.d, M.D
Urology — Payments: $24,646
Urology $24,646
Dr. Jason Anast, M.d, M.D
Urology — Payments: $22,457
Urology $22,457
Christian Hettinger, M.d, M.D
Urology — Payments: $18,826
Urology $18,826
Andrew Morris, D.o, D.O
Urology — Payments: $6,595
Urology $6,595
Mirian Boci, M.d, M.D
Urology — Payments: $5,842
Urology $5,842
Dr. Eric Deroo, Md, MD
Urology — Payments: $5,155
Urology $5,155